Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
dc.contributor.author | Bashir, Samir Al | en_US |
dc.contributor.author | Alshalalfa, Mohammed | en_US |
dc.contributor.author | Hegazy, Samar A | en_US |
dc.contributor.author | Dolph, Michael | en_US |
dc.contributor.author | Donnelly, Bryan | en_US |
dc.contributor.author | Bismar, Tarek A | en_US |
dc.date.accessioned | 2014-06-12T21:47:13Z | |
dc.date.available | 2014-06-12T21:47:13Z | |
dc.date.issued | 2014-03-07 | |
dc.description | Article deposited according to publisher policies: http://www.biomedcentral.com/about/copyright June 12, 2014 | en_US |
dc.description.refereed | Yes | en_US |
dc.description.sponsorship | Funding provided by the Open Access Authors Fund | en_US |
dc.identifier.citation | Al Bashir et al.: Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis. Journal of Hematology & Oncology 2014 7:21. doi:10.1186/1756-8722-7-21 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/33855 | |
dc.identifier.uri | http://hdl.handle.net/1880/50041 | |
dc.language.iso | eng | en_US |
dc.publisher | BioMed Central | en_US |
dc.publisher.corporate | University of Calgary | en_US |
dc.publisher.faculty | Medicine | en_US |
dc.publisher.url | http://www.jhoonline.org/content/7/1/21 | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis | en_US |
dc.type | journal article | |
thesis.degree.discipline | Pathology and Laboratory Medicine | en_US |
thesis.degree.discipline | Oncology | |
thesis.degree.discipline | Biochemistry | |
thesis.degree.discipline | Molecular Biology | |
thesis.degree.discipline | Urology |